CA A Cancer Journal for Clinicians· 2019Q1
Kanser Tedavisi ve Hayatta Kalma İstatistikleri, 2019
Cancer treatment and survivorship statistics, 2019
- 4.419atıf
- Q1SCImago
- 2019yıl
Kısa özet
1 Ocak 2019 itibarıyla 16,9 milyondan fazla Amerikalı kanser geçmişiyle hayattaydı ve bu sayının 2030 yılına kadar 22,1 milyonu aşması bekleniyor.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- 1 Ocak 2019 itibarıyla 16,9 milyondan fazla Amerikalı kanser hastasıydı.
- Hayatta kalanların sayısının 1 Ocak 2030'a kadar 22,1 milyonu aşması bekleniyor.
- Hayatta kalanların %56'sı son 10 yıl içinde teşhis edildi.
- Kanserden kurtulanların %64'ü 65 yaş ve üstü.
- Erkeklerde en yaygın kanserler prostat, kolon/rektum ve cilt melanomu; kadınlarda ise meme, rahim ve kolon/rektumdur.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
The number of cancer survivors continues to increase in the United States because of the growth and aging of the population as well as advances in early detection and treatment. To assist the public health community in better serving these individuals, the American Cancer Society and the National Cancer Institute collaborate every 3 years to estimate cancer prevalence in the United States using incidence and survival data from the Surveillance, Epidemiology, and End Results cancer registries; vital statistics from the Centers for Disease Control and Prevention's National Center for Health Statistics; and population projections from the US Census Bureau. Current treatment patterns based on information in the National Cancer Data Base are presented for the most prevalent cancer types. Cancer-related and treatment-related short-term, long-term, and late health effects are also briefly described. More than 16.9 million Americans (8.1 million males and 8.8 million females) with a history of cancer were alive on January 1, 2019; this number is projected to reach more than 22.1 million by January 1, 2030 based on the growth and aging of the population alone. The 3 most prevalent cancers in 2019 are prostate (3,650,030), colon and rectum (776,120), and melanoma of the skin (684,470) among males, and breast (3,861,520), uterine corpus (807,860), and colon and rectum (768,650) among females. More than one-half (56%) of survivors were diagnosed within the past 10 years, and almost two-thirds (64%) are aged 65 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by follow-up care providers. Although there are growing numbers of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence-based resources are needed to optimize care.
Yazarların özeti; kaynağından alınmıştır. CA A Cancer Journal for Clinicians, 2019 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Onkoloji
OncologyMedicine